Viglimet 50 mg+850 mg Tablet

Viglimet 50 mg+850 mg Tablet Overview

What Is Viglimet 50 mg+850 mg Tablet?

Viglimet combines vildagliptin, a DPP-4 inhibitor, with metformin in a single tablet, offering dual-mechanism glucose control for type 2 diabetes patients who need more than metformin alone.

Why Combine a DPP-4 Inhibitor with Metformin?

Vildagliptin works by preserving incretin hormones that stimulate insulin release after meals and suppress excess glucagon, complementing metformin's liver-focused glucose-lowering action — together offering a more comprehensive approach without the weight gain often seen with sulfonylureas.

Mechanism of Action

Vildagliptin inhibits the DPP-4 enzyme, prolonging the action of GLP-1 and GIP hormones to enhance glucose-dependent insulin secretion, while metformin reduces hepatic glucose production and improves insulin sensitivity.

Approved Indications

Type 2 diabetes mellitus in adults inadequately controlled on metformin alone, as an add-on combination therapy.

Dosing Guidance

Typically one tablet twice daily with meals, as directed by your physician based on your individual glycemic targets.

Important Safety Considerations

Liver function should be monitored periodically with vildagliptin use, and the medicine should be avoided in patients with significant hepatic impairment.

Side Effects

Common effects include mild gastrointestinal upset, headache, and dizziness; rarely, joint pain has been reported with DPP-4 inhibitors.

Drug Interactions

Inform your doctor about other diabetes medicines, especially insulin or sulfonylureas, as combining them can increase the risk of low blood sugar.

Storage

Store below 30°C, away from moisture and direct light.

Frequently Asked Questions

Q1: How is Viglimet different from taking metformin alone?

A1: It adds vildagliptin's incretin-based mechanism, offering an additional pathway for blood sugar control beyond what metformin provides on its own.

Q2: Does this combination cause hypoglycemia?

A2: The risk is generally low when used alone, but it increases if combined with insulin or sulfonylureas.

Q3: Will I need liver function tests while on this medicine?

A3: Yes, periodic liver function monitoring is recommended due to the vildagliptin component.

Q4: Can this replace insulin therapy?

A4: No, this is an oral combination therapy and is not a substitute for insulin in patients who require it; follow your doctor's treatment plan.

Medical Disclaimer: This information is provided for educational purposes only and does not replace professional medical advice. Always consult a registered physician before starting, stopping, or changing any medication.